Engineered Cas12a-Plus nuclease enables gene editing with enhanced activity and specificity.
Hongxin HuangGuanjie HuangZhihong TanYong-Fei HuLin ShanJia-jian ZhouXin ZhangShufeng MaWeiqi LvTao HuangYuchen LiuLiqiang WangXiao-Yang ZhaoYing LinZhili RongPublished in: BMC biology (2022)
Our discoveries provide alternative AsCas12a and LbCas12a variants with high specificity and activity, which expand the gene-editing toolbox and can be more suitable for clinical applications.